Breast Cancer News

Statin use after breast cancer diagnosis was associated with reduced breast cancer mortality and reduced serum cholesterol levels compared with not using a statin, according to cohort study results published in JAMA Network Open.

To address ongoing chemotherapy drug shortages, ASCO convened a multidisciplinary panel of oncologists, ethicists and patient advocates to expedite clinical guidance for navigating care where rationing or alternative therapies are needed.

Persistent chemotherapy-related amenorrhea was common and associated with worse long-term quality of life for premenopausal women with breast cancer, according to findings published in JAMA Network Open.

Significant advancements have been made in the de novo metastatic breast cancer space, including novel agents targeting the HER2 protein and others that enhance anti-estrogen therapies.

Precision oncology therapies requiring biomarker testing comprised 43% of all FDA oncology drug approvals between 1998 and 2022, study results published in Cancer Discovery showed.

President Joe Biden today announced his intention to appoint oncologist, researcher and educator, W. Kimryn Rathmell, MD, PhD, as director of the NCI.

Cancer-related mortality and leading causes of cancer death occurred more frequently in nonmetropolitan areas and among individuals with limited education, according to biennial report from the American Cancer Society.

The FDA approved capivasertib as part of combination therapy for certain patients with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer.

The number of cancer surgeries, chemotherapy treatments and radiation treatments declined dramatically during the first months of the COVID-19 pandemic, study findings published in JAMA Oncology showed.

PHILADELPHIA — Older adults with heart failure have worse physical and mental health than those with several types of cancer, a speaker reported at the American Heart Association Scientific Sessions.